DiaSorin nabs FDA clearance for infectious disease blood test

By LabPulse.com staff writers
July 22, 2022

Saluggia, Italy-based DiaSorin on Friday announced that it has obtained U.S. Food and Drug Administration (FDA) clearance for the Liaison MeMed BV, its host-protein signature-based assay.

The fully automated test utilizes host response-based data to enable physicians to differentiate accurately between bacterial and viral infections, supporting faster and better-informed treatment and patient management decisions, DiaSorin said.

The test also drives laboratory operational efficiency through time-labor reduction by using a fully automated and high-throughput approach when compared with traditional growth-based microbiology methods, the firm added.

The company said it is launching the blood-based assay in the U.S. and noted that the launch follows a licensing agreement inked with MeMed in September 2020.

Under the agreement, DiaSorin obtained the rights to commercialize and make the MeMed BV test available on its large installed base of Liaison platforms.

The test provides a valuable tool in the growing global threat posed by antimicrobial resistance, DiaSorin said.

The firm announced the clearance ahead of AACC 2022 in Chicago.

DiaSorin updates assay to detect omicron variant
DiaSorin Molecular recently released an updated version of its Simplexa Variants Direct assay to detect mutations associated with the new omicron variant...
Qiagen, DiaSorin partner on TB screening
The U.S. Food and Drug Administration has approved Qiagen's Liaison QuantiFeron-TB Gold Plus assay for use on DiaSorin's automated Liaison XS platform....
DiaSorin completes Luminex acquisition for $1.8B
DiaSorin has completed its acquisition of Luminex in a deal valued at $1.8 billion. The acquisition gives DiaSorin access to Luminex's multiplexing...
Qiagen, DiaSorin debut Lyme disease assay
Qiagen and DiaSorin announced the launch of the Liaison LymeDetect assay for early detection of the Lyme Borreliosis infection. The test detects immunoglobulin...

Copyright © 2022 LabPulse.com

Last Updated 7/25/2022 1:04:13 PM